Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 131   

Articles published

JNJ 100.22 +0.04 (0.04%)
price chart
Consumer group alleges 'reckless conduct' on part of Johnson & Johnson
A consumer advocacy group today requested that the U.S. Senate investigate Johnson & Johnson for what it called �a pattern of reckless conduct,� one month after calling on the Department of Justice to review whether the health care giant knowingly ...
Johnson & Johnson Profit Jumps As Prescription Drug Sales Surge And Outlook ...
Johnson & Johnson, the maker of medicines like Tylenol and consumer products like Aveeno and Listerine, reported $18.1 billion in first quarter revenue, beating Street estimates of $17.99 billion and coming in 3.5% above the $17.5 billion reported for ...
Johnson & Johnson Earnings: Will Tuesday Bring More Good News for J&J?  Motley Fool
Johnson & Johnson Reports 2014 First-Quarter Results:  Wall Street Journal
Related articles »  
How Johnson & Johnson Became A Household Name
New Brunswick, N.J.-based Johnson & Johnson (NYSE:JNJ) is probably most famous as the parent company of multiple household products that double as household names.
Group Calls For US Senate To Investigate Johnson & Johnson, CEO
New Brunswick, NJ - Women living with chronic injuries after being implanted with defective pelvic mesh devices have demanded a US Senate Investigation into Johnson & Johnson (NYSE:JNJ) and it's CEO Alex Gorsky for their destruction of thousands of ...
Short Interest in Johnson & Johnson Increases By 9.6% (JNJ)  Ticker Report
Johnson & Johnson Short Interest Up 9.6% in March (JNJ)  Mideast Time
Related articles »  
Why Johnson & Johnson Is Outperforming the Dow
Another health care stock, Johnson & Johnson (NYSE: JNJ ) , has gained nearly 9% to become the Dow's third best-performing stock this year.
Johnson & Johnson's New Diabetes Drug: A Blockbuster in the Making?
A major reason for that jump is a new wave of therapies, including Invokana, that are designed to improve how the body eliminates glucose.
Related articles »  
Johnson & Johnson Stock Attractive as It Raises Forecast
But Johnson & Johnson has delivered its share of winners that are fueling better-than-expected profit growth for the health-care giant.
Is Johnson & Johnson's Dividend Unbeatable?  Motley Fool
Why Johnson & Johnson Can Be Prescribed For Most Investors  Seeking Alpha
Related articles »  
Johnson & Johnson Ending Plans for Botox Rival
Johnson & Johnson Ending Plans for Botox Rival. Health-Care Company Acquired Wrinkle Fighter PurTox in $1.1 Billion Purchase of Mentor.
J&J says halting development of Botox rival  Reuters
Related articles »  
Johnson & Johnson to Host Medical Devices & Diagnostics Business Review
Dominic J. Caruso, Vice President, Finance and Chief Financial Officer will host the meeting which will feature presentations by Johnson & Johnson's senior management within the Medical Devices and Diagnostics organization. The agenda for the day will ...
Johnson & Johnson's Earnings Made Easy
Johnson & Johnson's (NYSE: JNJ ) recently reported earnings and the massive health-care conglomerate posted another strong performance.
More great jobs at  Worcester Telegram
Related articles »